Open Access
CC BY 4.0 · Journal of Diabetes and Endocrine Practice
DOI: 10.1055/s-0045-1812089
Original Article

Impact of Albuminuria and Renal Function on Ramadan Fasting in Type 2 Diabetes

Authors

  • Bachar Afandi

    1   Division of Endocrinology, Tawam Hospital and Sheikh Tahnoun Medical City, Al Ain, United Arab Emirates
    2   Department of Internal Medicine, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates
  • Yakoob Ahmedani

    3   Department of Diabetes, Tabba Heart Institute, Karachi, Pakistan
  • Yousef Boobes

    4   Department of Nephrology, Seha Kidney Care, Tawam Hospital, Al Ain, United Arab Emirates
  • Alaaeldin Bashier

    5   Department of Diabetes and Endocrinology, Dubai Hospital, Dubai, United Arab Emirates
    6   Department of Medicine, Mohammed Bin Rashid University, Dubai, United Arab Emirates
  • Sanobia Yousef

    3   Department of Diabetes, Tabba Heart Institute, Karachi, Pakistan
  • Georgios Ponirakis

    7   Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar
  • Rayaz A. Malik

    7   Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar
  • Reem Alamoudi

    8   Department of Endocrinology, King Saud bin Abdulaziz University, King Abdulaziz Medical City, King Saud University, Jeddah, Saudi Arabia
  • Inass Shaltout

    9   Department of Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
  • Rachid Malek

    10   Department of Endocrinology, Setif University Ferhat Abbas, Algiers, Algeria
  • Zanariah Hussein

    11   Medical Endocrine Unit, Department of Internal Medicine, Endocrine Institute Hospital, Putrajaya, Malaysia
  • Khadija Hafidh

    12   Diabetes Unit, Rashid Hospital, Dubai, United Arab Emirates
  • Mohamed Hassanein

    5   Department of Diabetes and Endocrinology, Dubai Hospital, Dubai, United Arab Emirates
    6   Department of Medicine, Mohammed Bin Rashid University, Dubai, United Arab Emirates

Funding Sources None.

Abstract

Background

Diabetic kidney disease (DKD) is a common and serious complication, defined by albuminuria and/or reduced estimated glomerular filtration rate (eGFR).

Objectives

This study explored the impact of DKD and its subgroups on glycemic control and fasting safety during Ramadan.

Patients and Methods

We analyzed data from the Diabetes and Ramadan Global Survey (2020–2022), including 12,529 participants with type 2 diabetes across seven regions. Participants were classified into four groups: no DKD (n = 10,780), DKD with albuminuria only (n = 460), DKD with low eGFR only (n = 1,150), and DKD with both albuminuria and low eGFR (n = 140). Outcomes included fasting patterns, hypoglycemia, hyperglycemia, and related interruptions.

Results

Most participants intended to fast (no DKD 86.5%, albuminuria only 80.0%, low eGFR only 76.4%, and albuminuria + low eGFR 80.6%). Mean fasting duration was ∼27 days across groups; however, those with reduced eGFR were more likely to fast only 1 to 7 days (6.4 vs. 2.4% without DKD, p < 0.0001). Daytime hypoglycemia occurred in 14.5% (no DKD), 19.0% (albuminuria only), 23.7% (low eGFR only), and 25.0% (albuminuria + low eGFR). Breaking fast due to hypoglycemia was more frequent in DKD groups (14.9–19.6 vs. 8.2% without DKD, p < 0.0001). Hyperglycemia was most frequent in albuminuria only (24.2%) and low eGFR only (18.4%) compared with no DKD (14.5%, p < 0.0001). Severe hyperglycemia was highest in low eGFR-only (2.0 vs. 0.8% without DKD, p < 0.001).

Conclusion

Ramadan fasting is common among people with type 2 diabetes and DKD, but carries greater risks of both hypoglycemia and hyperglycemia. Albuminuria may signal reduced physiological resilience and glycemic stability, even when eGFR is preserved, while reduced eGFR confers the highest risk. Comprehensive pre-Ramadan assessment and tailored education are essential to support safer fasting in this high-risk population.

Authors' Contribution

All authors contributed to the conception, data collection, writing, and final approval of the manuscript.


Compliance with Ethical Principles

Ethical approval was granted for the initial DAR Global Survey from the Dubai Health Authority.




Publication History

Article published online:
31 October 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Habas Sr E, Errayes M, Habas E. et al. Fasting Ramadan in chronic kidney disease (CKD), kidney transplant and dialysis patients: review and update. Cureus 2022; 14 (05) e25269
  • 2 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (05) 1047-1053
  • 3 Karatas A, Canakci E, Arici YK, Kaya M, Sayim B. The effect of fasting during Ramadan on the kidney functions of stage III-IV chronic kidney disease patients. Pak J Med Sci 2021; 37 (04) 972-978
  • 4 NasrAllah MM, Osman NA. Fasting during the month of Ramadan among patients with chronic kidney disease: renal and cardiovascular outcomes. Clin Kidney J 2014; 7 (04) 348-353
  • 5 Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. Fasting Ramadan in chronic kidney disease patients: clinical and biochemical effects. Saudi J Kidney Dis Transpl 2010; 21 (05) 898-902
  • 6 Afandi B, Kaplan W, Al Kuwaiti F, Al Dahmani K, Nagelkerke N. Ramadan challenges: fasting against medical advice. J Fasting Health 2017; 5 (03) 133-137
  • 7 El-Wakil HS, Desoky I, Lotfy N, Adam AG. Fasting the month of Ramadan by Muslims: could it be injurious to their kidneys?. Saudi J Kidney Dis Transpl 2007; 18 (03) 349-354
  • 8 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
  • 9 Hendawy A. Effect of Fasting on Renal Physiology. J Fasting Health 2014; 2 (03) 110-112
  • 10 Hassanein M, Yousuf S, Ahmedani MY. et al. Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: the DaR global survey. Diabetes Metab Syndr 2023; 17 (07) 102799
  • 11 Boobes Y, Afandi B, AlKindi F. et al. Consensus recommendations on fasting during Ramadan for patients with kidney disease: review of available evidence and a call for action (RaK Initiative). BMC Nephrol 2024; 25 (01) 84
  • 12 Babineaux SM, Toaima D, Boye KS. et al. Multi-country retrospective observational study of the management and outcomes of patients with type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 2015; 32 (06) 819-828
  • 13 Hassanein M, Al Awadi FF, El Hadidy KES. et al. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: an international prospective study (DAR-MENA T2DM). Diabetes Res Clin Pract 2019; 151: 275-284
  • 14 Salti I, Bénard E, Detournay B. et al; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27 (10) 2306-2311
  • 15 Ahmadani MY, Riaz M, Fawwad A, Hydrie MZ, Hakeem R, Basit A. Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan. Pak J Biol Sci 2008; 11 (16) 2044-2047
  • 16 Elmehdawi RR, Mukhtad NA, Allaghi NI, Elmajberi SJ. Fasting of Ramadan in people with diabetes in Benghazi, Libya: an exploratory study. Libyan J Med 2010; 5: 5234
  • 17 Baynouna AlKetbi L, Nagelkerke N, AlZarouni A. et al. Ramadan fasting outcome among high-risk patients. BMC Nephrol 2022; 23 (01) 304
  • 18 Alawadi F, Rashid F, Bashier A. et al. The use of Free Style Libre continues glucose monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care. Diabetes Res Clin Pract 2019; 151: 305-312
  • 19 Gad H, Al-Muhannadi H, Purra H, Mussleman P, Malik RA. The effect of Ramadan focused education on patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 2020; 162: 108122
  • 20 Al Wakeel J, Mitwalli AH, Alsuwaida A. et al. Recommendations for fasting in Ramadan for patients on peritoneal dialysis. Perit Dial Int 2013; 33 (01) 86-91
  • 21 Ghalib M, Qureshi J, Tamim H. et al. Does repeated Ramadan fasting adversely affect kidney function in renal transplant patients?. Transplantation 2008; 85 (01) 141-144
  • 22 Qurashi S, Tamimi A, Jaradat M, Al Sayyari A. Effect of fasting for Ramadan on kidney graft function during the hottest month of the year (August) in Riyadh, Saudi Arabia. Exp Clin Transplant 2012; 10 (06) 551-553
  • 23 Shaikh S, Latheef A, Razi SM, Khan SA, Sahay R, Kalra S. Diabetes management during Ramadan. In: Feingold KR, Ahmed SF, Anawalt B. et al, eds Endotext [Internet]. South Dartmouth, MA: MDText.com, Inc.; 2000
  • 24 Alghamdi AS, Alghamdi KA, Jenkins RO, Alghamdi MN, Haris PI. Impact of Ramadan on physical activity and sleeping patterns in individuals with type 2 diabetes: the first study using Fitbit device. Diabetes Ther 2020; 11 (06) 1331-1346
  • 25 Alfadhli EM. Higher rate of hyperglycemia than hypoglycemia during Ramadan fasting in patients with uncontrolled type 1 diabetes: insight from continuous glucose monitoring system. Saudi Pharm J 2018; 26 (07) 965-969
  • 26 Saadane I, Ali T, El-Laboudi A, Lessan N. Ramadan fasting in insulin-treated patients is associated with potentially unfavourable changes in glucose metrics: a flash glucose monitoring (FGM) study. Diabetes Res Clin Pract 2021; 172: 108592